Yu-Hsin Yang

Ms. Yu-Hsin Yang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WLWen Chun Liu
Wen Chun Liu
YYYu-Hsin Yang
Yu-Hsin Yang
YWYu-Chin Wang
Yu-Chin Wang
WCWei-Min Chang
Wei-Min Chang
CWChin-Wei Wang
Chin-Wei Wang
Maresins are lipid mediators derived from omega-3 fatty acids with anti-inflammatory and pro-resolving properties, capable of promoting tissue regeneration and potentially serving as a therapeutic agent for chronic inflammatory diseases. The aim of this review was to systematically investigate preclinical and clinical studies on maresin to inform translational research. Two independent reviewers performed comprehensive searches with the term “Maresin (NOT) Review” on PubMed. A total of 137 studies were included and categorized into 11 human organ systems. Data pertinent to clinical translation were specifically extracted, including delivery methods, optimal dose response, and specific functional efficacy. Maresins generally exhibit efficacy in treating inflammatory diseases, attenuating inflammation, protecting organs, and promoting tissue regeneration, mostly in rodent preclinical models. The nervous system has the highest number of original studies (n = 25), followed by the cardiovascular system, digestive system, and respiratory system, each having the second highest number of studies (n = 18) in the field. Most studies considered systemic delivery with an optimal dose response for mouse animal models ranging from 4 to 25 μg/kg or 2 to 200 ng via intraperitoneal or intravenous injection respectively, whereas human in vitro studies ranged between 1 and 10 nM. Although there has been no human interventional clinical trial yet, the levels of MaR1 in human tissue fluid can potentially serve as biomarkers, including salivary samples for predicting the occurrence of cardiovascular diseases and periodontal diseases; plasma and synovial fluid levels of MaR1 can be associated with treatment response and defining pathotypes of rheumatoid arthritis. Maresins exhibit great potency in resolving disease inflammation and bridging tissue regeneration in preclinical models, and future translational development is warranted.

30 October 2025 in Microbiology Research
Verified
Journal Article
Open access
PDF file
YYYu-Hsin Yang
Yu-Hsin Yang
JYJing Jie Yu
Jing Jie Yu
WCWei-Min Chang
Wei-Min Chang
Haw-Ming HuangHaw-Ming Huang
Haw-Ming Huang
CWChin-Wei Wang
Chin-Wei Wang
Sapindus mukorrosi (Sm) seeds have been used in Chinese medicine for treating gingival disease, suggesting that Sm may modulate oral bacteria and alleviate gingival inflammation. However, the hydrophobicity of seed oil limits its use in the aqueous oral environment. Therefore, the artificial saliva-infused Sm seed aqueous extract (SMa) was developed and applied to our ex vivo model to test its anti-bacterial effect. Unstimulated whole saliva from seven patients with Stage III/IV, Grade C periodontitis was cultured for 8 h with or without SMa. The bacterial count was measured based on the optical density and bacterial DNA concentration. The salivary microbiome was sequenced via next-generation sequencing over the 16S rRNA gene V3-V4 hypervariable regions. The bacterial DNA concentration in the SMa group was significantly lower than the Without-SMa group after 6 to 8 h of culture. No significant difference in alpha and beta diversity was observed between the two groups. The relative abundance of Porphyromonas was reduced, while that of Veillonella was elevated in the SMa group compared to the Without-SMa group. The findings indicated that the antibacterial effects of SMa are manifested primarily through bacterial growth inhibition, with the minor modulation of specific taxa.